Literature DB >> 27316747

Oxidative stress, protein modification and Alzheimer disease.

A Tramutola1, C Lanzillotta1, M Perluigi1, D Allan Butterfield2.   

Abstract

Alzheimer disease (AD) is a progressive neurodegenerative disease that affects the elderly population with complex etiology. Many hypotheses have been proposed to explain different causes of AD, but the exact mechanisms remain unclear. In this review, we focus attention on the oxidative-stress hypothesis of neurodegeneration and we discuss redox proteomics approaches to analyze post-mortem human brain from AD brain. Collectively, these studies have provided valuable insights into the molecular mechanisms involved both in the pathogenesis and progression of AD, demonstrating the impairment of numerous cellular processes such as energy production, cellular structure, signal transduction, synaptic function, mitochondrial function, cell cycle progression, and degradative systems. Each of these cellular functions normally contributes to maintain healthy neuronal homeostasis, so the deregulation of one or more of these functions could contribute to the pathology and clinical presentation of AD. In particular, we discuss the evidence demonstrating the oxidation/dysfunction of a number of enzymes specifically involved in energy metabolism that support the view that reduced glucose metabolism and loss of ATP are crucial events triggering neurodegeneration and progression of AD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP synthase; Alzheimer disease; Glucose metabolism; Oxidative stress; Protein oxidation

Mesh:

Substances:

Year:  2016        PMID: 27316747     DOI: 10.1016/j.brainresbull.2016.06.005

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  62 in total

Review 1.  Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease.

Authors:  Thuy Trang Nguyen; Tuong Kha Vo; Giau Van Vo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Photobiomodulation and the brain: a new paradigm.

Authors:  Madison Hennessy; Michael R Hamblin
Journal:  J Opt       Date:  2016-12-14       Impact factor: 2.516

3.  Enhancement of the Antioxidant Activity and Neurotherapeutic Features through Pyridol Addition to Tetraazamacrocyclic Molecules.

Authors:  Hannah M Johnston; Kristof Pota; Madalyn M Barnett; Olivia Kinsinger; Paige Braden; Timothy M Schwartz; Emily Hoffer; Nishanth Sadagopan; Nam Nguyen; Yu Yu; Paulina Gonzalez; Gyula Tircsó; Hongli Wu; Giridhar Akkaraju; Michael J Chumley; Kayla N Green
Journal:  Inorg Chem       Date:  2019-11-27       Impact factor: 5.165

4.  Protective Effects of Co-administration of Zinc and Selenium Against Streptozotocin-Induced Alzheimer's Disease: Behavioral, Mitochondrial Oxidative Stress, and GPR39 Expression Alterations in Rats.

Authors:  Yaghoob Farbood; Alireza Sarkaki; Masoud Mahdavinia; Ata Ghadiri; Ali Teimoori; Faezeh Seif; Mohammad Amin Dehghani; Seyedeh Parisa Navabi
Journal:  Neurotox Res       Date:  2020-06-05       Impact factor: 3.911

5.  Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer's Disease Are Associated with Oxidative Stress Regulation Mechanisms.

Authors:  Sarah Patrick; Rachel Corrigan; John Grizzanti; Megan Mey; Jeff Blair; Merce Pallas; Antonio Camins; Hyoung-Gon Lee; Gemma Casadesus
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

6.  Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study.

Authors:  Hannah M Jester; Saahj P Gosrani; Huiping Ding; Xueyan Zhou; Mei-Chuan Ko; Tao Ma
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 7.  Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer's Disease.

Authors:  Giusy Tassone; Arian Kola; Daniela Valensin; Cecilia Pozzi
Journal:  Life (Basel)       Date:  2021-04-24

8.  Development and in vivo Evaluation of Hydroxy-α-Sanshool Intranasal Liposomes as a Potential Remedial Treatment for Alzheimer's Disease.

Authors:  Ruolan Li; Feng Lu; Xue Sun; Liying He; HuXinyue Duan; Wei Peng; ChunJie Wu
Journal:  Int J Nanomedicine       Date:  2022-01-11

Review 9.  Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential.

Authors:  Yashi Mi; Guoyuan Qi; Roberta Diaz Brinton; Fei Yin
Journal:  Antioxid Redox Signal       Date:  2020-04-21       Impact factor: 8.401

10.  Hispidin inhibits LPS-induced nitric oxide production in BV-2 microglial cells via ROS-dependent MAPK signaling.

Authors:  Mei-Hua Jin; Dong-Qin Chen; Ying-Hua Jin; Ying-Hao Han; Hu-Nan Sun; Taeho Kwon
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.